Volume 2, 2023

Recent advances in PAMAM dendrimer-based CT contrast agents for molecular imaging and theranostics of cancer

Abstract

Construction of poly(amidoamine) (PAMAM) dendrimer-based nanoplatforms for tumor computed tomography (CT) imaging and theranostics has gained significant attention in recent years. The unique characteristics of PAMAM dendrimers such as monodispersity, highly branched interior, and 3-dimensional architecture allow them to be widely used in the field of biomedicine, especially for tumoral delivery of contrast agents. With the help of PAMAM dendrimers, traditional contrast agents easily accumulate at tumor sites, resulting in accurate diagnostics. Moreover, contrast agents and anticancer drugs can be integrated by PAMAM dendrimers to form multifunctional platforms for cancer theranostics. In this review, we summarize the recent advances in the construction of PAMAM dendrimer-based nanoplatforms for tumor CT imaging and theranostics, including the optimization of platform design, imaging performance, and theranostics. The challenges and future development strategies for dendrimer-based nanoplatforms towards laboratory study and practical biomedical applications are also discussed.

Graphical abstract: Recent advances in PAMAM dendrimer-based CT contrast agents for molecular imaging and theranostics of cancer

Article information

Article type
Critical Review
Submitted
28 4月 2023
Accepted
18 8月 2023
First published
18 8月 2023
This article is Open Access
Creative Commons BY-NC license

Sens. Diagn., 2023,2, 1145-1157

Recent advances in PAMAM dendrimer-based CT contrast agents for molecular imaging and theranostics of cancer

T. Huang, G. Li, Y. Guo, G. Zhang, D. Shchabin, X. Shi and M. Shen, Sens. Diagn., 2023, 2, 1145 DOI: 10.1039/D3SD00101F

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements